Format

Send to

Choose Destination
Neurotherapeutics. 2011 Jan;8(1):93-102. doi: 10.1007/s13311-010-0006-0.

Neuroimaging in psychiatric disorders.

Author information

1
Section on Integrative Neuroimaging, Intramural Research Program, National Institutes of Health (NIH/NIMH-CBDB), Bethesda, Maryland 20892-1365, USA. masdeu@nih.gov

Abstract

In psychiatry, neuroimaging facilitates the diagnosis of psychiatric disorders and the development of new medications. It is used to detect structural lesions causing psychosis and to differentiate depression from neurodegenerative disorders or brain tumors. Functional neuroimaging, mostly in the form of molecular neuroimaging with positron emission tomography or single photon emission tomography, facilitates the identification of therapeutic targets, the determination of the dose of a new drug needed to occupy its target in the brain, and the selection of patients for clinical trials.

PMID:
21274689
PMCID:
PMC3052989
DOI:
10.1007/s13311-010-0006-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center